Tempo Therapeutics Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 15

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.37M

  • Investors
  • 3

Tempo Therapeutics General Information

Description

Operator of life science company intended to administer regenerative tissue treatments. The company's hydrogel uses cell-free synthetic materials that use geometric technology to unlock the body's own regenerative capacity and control inflammation, enabling patients to achieve accelerated healing rates, reduced chronic tissue inflammation, and increased regenerative healing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3030 Bunker Hill Street
  • Suite 104
  • San Diego, CA 92109
  • United States
+1 (251) 000-0000

Tempo Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tempo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 15-Sep-2021 $1.37M 00.000 Completed Pre-Clinical Trials
6. Angel (individual) 00000 00.000 Completed Startup
5. Seed Round 01-Jun-2020 00.000 00.000 000.00 Completed Pre-Clinical Trials
4. Grant 01-Jan-2020 00000 Completed Pre-Clinical Trials
3. Grant 01-Jan-2019 00.00 Completed Pre-Clinical Trials
2. Grant 01-Jan-2016 $225K Completed Startup
1. Angel (individual) Cancelled Startup
To view Tempo Therapeutics’s complete valuation and funding history, request access »

Tempo Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view Tempo Therapeutics’s complete cap table history, request access »

Tempo Therapeutics Patents

Tempo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200237964-A1 Methods of manufacturing injectable microgel scaffolds Pending 29-Dec-2016 000000000
US-20200222593-A1 Systems to promote healing at a site of a medical device Pending 29-Dec-2016 000000000 0
AU-2017394923-B2 Methods and systems for treating a site of a medical implant Active 29-Dec-2016 000000000 0
AU-2017394923-A1 Methods and systems for treating a site of a medical implant Active 29-Dec-2016 000000000
CA-3051055-A1 Methods and systems for treating a site of a medical implant Pending 29-Dec-2016 A61L27/52
To view Tempo Therapeutics’s complete patent history, request access »

Tempo Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Westbrook Weaver Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Donald Griffin Ph.D Co-Founder, Chief Financial Officer, Chief Scientific Officer & Board Member
Philip Scumpia Ph.D Co-Founder & Clinical Advisor
Tatiana Segura Ph.D Co-Founder & Scientific Advisor
Steven Richieri Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Tempo Therapeutics Board Members (6)

Name Representing Role Since
Dino Di Carlo Ph.D Self Co-Founder & Board Member 000 0000
Donald Griffin Ph.D Tempo Therapeutics Co-Founder, Chief Financial Officer, Chief Scientific Officer & Board Member 000 0000
Richard Hancock Self Board Member 000 0000
Robin Sitver Self Board Member 000 0000
Steven Richieri Tempo Therapeutics Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Tempo Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tempo Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Tempo Therapeutics’s complete investors history, request access »